Chemotherapy and Progenitor Cell Transplantation to Treat Inflammatory Breast Cancer
Conditions: Breast Neoplasm; Neoplasm MetastasisInterventions: Drug: Monoclonal Antibody 3A1; Drug: Monoclonal Antibody 95-5-49; Drug: Monoclonal Antibody 95-6-22; Device: Baxter Isolex 3001 Stem Cell Selection System; Device: Ceprate SCSponsors: National Institutes of Health Clinical Center (CC); National Cancer Institute (NCI)Completed - verified June 2014
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Breast Cancer | Cancer | Cancer & Oncology | Chemotherapy | Health | Inflammatory Breast Cancer | National Institutes of Health (NIH) | Research | Stem Cell Therapy | Stem Cells | Transplants